Cosden M, Jinn S, Yao L, Gretzula CA, et al. A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy. Neurobiol Dis 2021;159:105507.
PMID: 34509608